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Abstract 19 
Osteochondrosis (OC) is a multifactorial defective endochondral ossification that causes 20 
lameness and early culling in gilts and sows. Previous research suggested that nutrition 21 
and growth rate could influence OC development and progression. As part of a broader 22 
study [n = 360 gilts; 28.8 ± 8.8 kg body weight (BW)] designed to evaluate the effect of 23 
4 dietary treatments: 1) basal diet (CON); 2) CON plus organic micro-minerals (MIN, 24 
copper, manganese and zinc at 10, 20 and 50 mg/kg, respectively); 3) additional 25 
methionine (MET, at 102% methionine:lysine); and, 4) the organic micro-minerals plus 26 
the additional methionine (MM), on lameness and performance, a sub-sample of 40 heavy 27 
replacement gilts (10 gilts/treatment, 171.5 ± 8.1 kg of BW) was used. Within treatment, 28 
gilts were classified for final average daily gain (ADG) as low (LG, 838 ± 36.3 g/day; n 29 
= 20) or high (HG, 922 ± 31.1 g/day; n = 20). Dietary treatment and growth classification 30 
were the fixed effects to evaluate gait, OC, tibia bending measures, metacarpal 31 
mineralization; and using computerized tomography, the carcass composition, bone size, 32 
and whole bone density (WBD). The WBD was expressed as volume of Hounsfield 33 
values (HU), where higher values indicate increased density. A porcine reproductive and 34 
respiratory syndrome virus outbreak occurred during this trial. It differentially affected 35 
MM gilt performance and consequently may have influenced the results for this treatment. 36 
Gilts fed MIN diet had 0.75 cm larger tibia than CON (P < 0.05), and 10% increase of 37 
WBD > 140 HU compared to CON and MET (P < 0.05). The volume of high dense bones 38 
(> 1,000 HU) was also increased in MIN and MET compared with CON (P < 0.05). Tibia 39 
bending moment and breakage strength were greater (P < 0.05) in MIN than in CON, 40 
with MET and MM intermediate. Metacarpal ash, Ca, and P content, but not proportions, 41 
were higher in gilts fed MIN than CON (P < 0.05). Total score of OC lesions was lower 42 
in MM gilts compared to CON (P < 0.05). The OC total score increased with ADG from 43 
35.8 to 109.8 kg BW (R2 = 0.10; P < 0.10). However, between 109.8 and 171.5 kg BW 44 
OC score increased with decreased ADG (R2 = 0.14; P < 0.05). In conclusion, 45 
supplementing growing gilts with MIN enhanced bone strength and bone density, MET 46 
increased the proportion of highly dense bone (>1,000 HU), and MM dietary treatment 47 
reduced OC lesion score compared with CON.  48 
Key words: Trace minerals, Osteochondrosis; Lameness; Bone; Pigs; Sows. 49 
1. Introduction 50 
Osteochondrosis (OC) is focal disturbance in endochondral ossification seen in 51 
growing animals (Olstad et al., 2015). The cartilage superficial OC lesions fracture is 52 
suggested to be a major cause of lameness in gilts (Koning et al., 2015), and lameness is 53 
a primary reason for gilt failure (Engblom et al., 2008). The OC prevalence is variable 54 
and can be high (41 to 100%) although by 6 months of age healing is described as being 55 
above 50% (Busch and Wachmann, 2011; Olstad et al., 2014; Grevenhof et al., 2012). 56 
Osteochondrosis is the result of a blood supply failure to the epiphyseal growth cartilage 57 
and ischemic chondronecrosis. The originating cause is controversial and may be 58 
influenced by genetics, growth rate, nutrition, conformation, and mechanical stress 59 
(Ytrehus et al., 2007; Koning et al., 2014; Olstad et al., 2015; Quinn et al., 2015; Le et 60 
al., 2016). For instance, Busch and Wachmann (2011) described that every 100 g increase 61 
in wean-to-finish average daily gain (ADG) increased risk of OC by 20%. 62 
Some nutrients are essential for bone and cartilage development and if 63 
supplemented may reduce OC and enhance healing (Riet et al., 2013). Zinc (Zn) impacts 64 
bone mass and is important for matrix quality (i.e. key in insulin-like growth factor-1, 65 
osteoblast, parathyroid hormone activations; Matsui and Yamaguchi, 1995; Veum et al., 66 
2009). Manganese (Mn) and copper (Cu) also participate in bone and cartilage matrix 67 
formation by being involved with proteoglycans and lysyl oxidase, respectively (Riet et 68 
al., 2013). 69 
The availability of inorganic trace minerals (TM) is often variable or unknown 70 
(Reese and Hill, 2010), which may lead to deficiency. A common practice to prevent this 71 
is to increase dietary levels above recommendations, which results in extra cost and 72 
environmental impact (Creech et al., 2004; Suttle, 2010). Organically bound minerals, 73 
may have higher retention compared with inorganic minerals, could minimize those 74 
problems and reduce content in the manure (Liu et al., 2016). Additionally, the European 75 
Union recently limited the inclusion of Zn to 150 mg/kg (European Commission, 2016), 76 
and Cu to 25 g/kg in pigs above 12 weeks of age (European Commission, 2003) in 77 
complete feeds.  78 
Other nutrients, such as methionine (Met) and threonine (Thr), have shown 79 
potential to reduce OC severity in growing pigs (Frantz et al., 2008). Such effects were 80 
attributed to Met, which is a source of sulfur known to enhance osteoblast differentiation 81 
and increase osteocalcin (Bottiglieri, 2002; Ouattara et al., 2016), and therefore, would 82 
benefit collagen and bone formation. 83 
We hypothesized that supplementing Cu, Mn, and Zn with additional Met would 84 
enhance bone and cartilage development. In addition, it was hypothesized that among 85 
heavy gilts, lower growth rate may include less risk of joint lesions and interact with 86 
dietary treatment. Therefore, the objective of this study was to assess the effect of 87 
supplementing the diet with organic TM (Cu, Mn, and Zn), Met or the combination on 88 
carcass composition, gait score, bone density, and OC in replacement gilts of different 89 
growth rate. 90 
2. Materials and methods 91 
The animals used were produced and housed in commercial swine facilities. The 92 
Ethical Committee on Animal Experimentation at the Universitat Autònoma de Barcelona 93 
reviewed and approved the procedures and protocols for the experiment according to the 94 
guidelines of the European Union (European Commission, 2010).  95 
2.1. Animals, experimental design, housing, and dietary treatments 96 
This study was part of a broader experiment designed to evaluate the effect of 4 97 
dietary treatments on lameness and performance (Fabà et al., 2018). A total of 360 young 98 
gilts [28.8 ± 8.8 kg body weight (BW)]; DanAvl Dania Hybrid line, Landrace × 99 
Yorkshire, DanBred Internacional, Sant Cugat del Vallés, Spain) were blocked and 100 
randomly assigned to 1 of 4 treatments: 1) control (CON, basal diet); 2) CON plus organic 101 
minerals (MIN, Cu, Mn, and Zn at 10, 20 and 50 mg/kg respectively; Aplomotec Plus, 102 
Tecnología & Vitaminas, S.L, Alforja, Spain); 3) additional Met [MET, at 102% 103 
Met:lysine (Lys)]; and 4) MET plus MIN (MM). The experimental diets were formulated 104 
for 3 different phases of 14, 75, and 45 day to include 10.7, 10.2, and 9.67 MJ net 105 
energy/kg and 11.5, 9.0, and 7.0 g/kg standarized ileal digestible (SID) Lys, respectively. 106 
For each experimental period, feeds were formulated to meet or exceed nutrient 107 
requirements (FEDNA, 2013) for proper gilt growth (see Table 1). Feed was pelleted and 108 
provided ad libitum using dry feeders with 1 space for 134 days. Gilts had free access to 109 
fresh water and enrichment items (biting iron chains and solid plastic balls). 110 
Forty of the 360 gilts were used in the study described herein. Initially, gilts were 111 
distributed into 36 pens and 3 blocks of BW (as 10 animals/pen and 0.90 m2/gilt with 112 
60% slatted and 40% solid floor in each pen). At the end of rearing, gilts were selected 113 
(171.5 ± 8.12 kg of BW and 221 ± 7.68 day of age) as 10 gilts per treatment among the 114 
120 heaviest gilts in the study. For each treatment, gilts were originally provided from 4 115 
pens with 4 gilts from 1 pen and the other 6 gilts from 3 different pens. Within each 116 
dietary treatment, the 10 gilts were proportionally divided according to growth rate as low 117 
growth (LG, 838 ± 36.3 g/day of ADG) or high growth (HG, 922 ± 31.1 g/day of ADG). 118 
The criteria to choose heavy gilts and ADG classification was that heavy animals with 119 
HG gilts were a population with higher risk of OC (Busch and Wachmann, 2011). The 40 120 
gilts were slaughtered in a commercial slaughterhouse and their left half carcass studied 121 
on a similar BW to gilts at first service.  122 
2.2. Measurements and sampling 123 
2.2.1. Chemical analysis in feeds 124 
Chemical composition of feeds for moisture determination (method 925.09), 125 
crude protein (method 968.06), crude fat (method 920.39), crude fiber (method 962.09), 126 
and acid detergent fiber (ADFom) expressed exclusive of residual ash (method 973.18) 127 
were determined according to AOAC (2000). Neutral detergent fiber (aNDFom) was 128 
assayed using sodium sulfite with a heat stable amylase and expressed exclusive of 129 
residual ash (Mertens, 2002). Furthermore, Lys and Met were determined [method 982.30 130 
E(a); AOAC International, 2006]. The hydroxy-analogue Met was analyzed using the 131 
HPLC method described by Wauters et al. (1990), and minerals Cu, Mn, and Zn using 132 
ICP-OES spectrometry (Perkin-Elmer, model Optima 4300DV; MA, USA). 133 
2.2.2. Growth, carcass traits and whole bone density by computerized tomography 134 
Measures of BW collected were on day 1, 41, 67, and 134 of the experimental 135 
period. The backfat (BF) and loin muscle depth were determined at 6 cm from the midline 136 
and at the level of the last rib using an ultrasound scanner (AV-3000V Digital Handheld 137 
Electronic B Ultrasound Scanner, AMBISEA Technology Corp., Ltd; Hong Kong, 138 
China). The 40 gilts were fasted for 12 h and transported to a local slaughterhouse where 139 
exsanguination occurred post CO2 stunning. Within 15 min after slaughter, hot carcass 140 
weight was recorded to calculate dressing percentage (= 100 × hot carcass weight / live 141 
weight), and then placed in a chilling room (4°C).  142 
Left half carcasses were transported to IRTA-Monells research institute (Institut 143 
de Recerca i Tecnologia Agroalimentaria, Monells, Spain). Carcasses were prepared 144 
following the European Reference Method (Walstra and Merkus, 1996) and were scanned 145 
with the General Electric HiSpeed Zx / I computed tomography device (GE Healthcare, 146 
Madrid, Spain). Acquisition parameters were 140 kV, 145 mA, 10 mm-thick, helical, 512 147 
× 512 matrix, displayed field of view 500 mm and reconstruction algorithm STD+ (Font-148 
i-Furnols et al., 2009). From the images of the whole half carcasses, it was obtained the 149 
distribution of volume by Hounsfield (HU) values with Matlab [Version 7.5.0.342 150 
(R2007b) The MathWorks, Inc., MA, USA]. Using the distribution of HU values, it was 151 
calculated the lean tissue percentage of the carcass using prediction equations previously 152 
developed by Font-i-Furnols et al. (2009).  153 
The HU distribution was also used to determine the whole bone density (WBD), 154 
which was calculated in 2 manners: 1) estimated by the formula developed by Picouet et 155 
al. (2010), and 2) considering bone density at HU >140 as previously described (Font-i-156 
Furnols et al., 2015). For 2) method, whole half carcass HU values higher than 140, 500, 157 
1,000 , and 1,500 were obtained, thus marrow is excluded. The use of these cut-off ranges 158 
were defined according to Gaudré et al. (2014), and therefore, used to compare 159 
proportions of different density threshold. The higher the HU value, the higher the density 160 
of the bone (Batawil and Sabiq, 2016). Hence, volume and (or) proportion of bone from 161 
different ranges of HU values is associated with higher or lower bone density. The density 162 
for specific bones was not measured and WBD refers to entire half left carcass.  163 
From the collected images and using Horos software (2016), femur and tibia 164 
length were measured. Furthermore, a transversal image from the middle of the femur 165 
and tibia bones provided the cortical bone area (total bone area minus marrow area).  166 
2.2.3. Tibia bending test 167 
Bending test of fresh tibia was determined using an MTS Material Testing 168 
Apparatus (Model 810, MTS Systems Corporation, Minneapolis, USA) in Escola Tècnica 169 
Superior d'Enginyeria Industrial de Barcelona (Departament de Resistència de Materials 170 
i Estructures; Universitat Politècnica de Catalunya, Spain) according to methodology 171 
described by Veum and Ellersieck (2008). Tibia was held on 2 supports spaced 120 mm 172 
apart and force was applied to the midpoint with crosshead speed constant at 6 mm/min. 173 
The bending maximum force as breakage strength (kN), bending depth (mm), total energy 174 
(area under the curve, kN), and bending moment (kN – mm) were reported. Bending 175 
moment, defined as applied force adjusted for the distance over which it is applied 176 
(Crenshaw et al., 1981), was calculated using the formula: bending moment = (F × L)/4, 177 
where F is a measure of the maximum load (kN) and L is the distance between the bottom 178 
2 fulcra (mm).  179 
2.2.4. Analysis of minerals in third metacarpal and serum 180 
The 3rd metacarpal of the left half carcass was collected, systematically boiled and 181 
cleaned of adherent tissue, diagonally cut in 2 pieces, weighed, dried (109ºC 12h), 182 
chemically cleaned (in acetone for 24h), dried (109ºC 12h), weighed again, and burned 183 
in a muffle-oven overnight (550ºC). The ash percentage was calculated and the 184 
metacarpal content of calcium (Ca), phosphorus (P), Zn, Mn, and Cu were analyzed using 185 
atomic absorption spectrophotometry at proper wavelength ICP-MS (Perkin-Elmer, 186 
model Optima 4300DV; MA, USA). Blood samples (10 ml) were collected at 187 
exsanguination post stunning (using siliconized blood-collecting tubes) and levels of Zn 188 
and Cu were analyzed in serum using ICP-OES spectrometry (Perkin-Elmer, model 189 
Optima 4300DV; MA, USA). 190 
2.2.5. Macroscopically assessment of joint lesions   191 
The elbow, carpal, femoral-iliac, knee, and tarsal joints of the left half carcass 192 
were opened and examined. All articular faces were gross evaluated for external 193 
abnormalities (defects in cartilage surface) as OC lesions on the articular cartilage. The 194 
joints were macroscopically evaluated by a board-certified veterinary pathologist, based 195 
on the methodology described by Kirk et al. (2008), and without knowledge of the dietary 196 
treatment assignment on the individual samples as blind assessment. Different locations 197 
were examined, and the presence of erosions, ulcerations, repair reactions, marginal 198 
osteophytes, and infolding of the joint were accounted as OC lesions (see the 199 
aforementioned study for the description and figures of lesion characteristics). Joint faces 200 
were scored for presence of lesions and their severity. The proportion of gilts with 201 
moderate or severe lesions was calculated; furthermore, the number of faces with lesions 202 
and total score of OC were collected for each gilt. The presence of lesions was scored as 203 
presence (1) or absence (0) of lesion on each articular face. The severity on each face was 204 
as scored as: none (0), small (1) when the lesion involved less than 5% of the cartilage 205 
surface, moderate (2) when the lesion was 5 to 10%, and severe (3) when fragmented 206 
cartilage was visible and lesion exceeded 10% of the cartilage surface (Figure 1). 207 
Proportion of moderate or severe lesions was the number of gilts with at least 1 moderate 208 
or severe lesion, respectively. The number of faces with lesion was the sum of faces with 209 
lesions for each gilt. Finally, total OC score was calculated as the sum of severities 210 
accumulated throughout all evaluated joint faces (0-9). Because none of the left carcasses 211 
evaluated showed more than 3 articular faces with lesions, the classification was defined 212 
as: articular face of tibia, femur, and “other joints” (gilts with elbow, carpal, or tarsal OC 213 
lesions). 214 
2.2.6. Locomotor capacity   215 
Even though gilts were selected to be non-lame (no limp), gait was evaluated and 216 
scored using an adapted methodology from Mustonen et al. (2011) as: 0, no-difficulty; 1, 217 
slight-difficulty and slower exercise; 2, moderate-difficulty with shortened stride and 218 
some problems to exercise; and 3, severe-difficulty with evident limp lameness and 219 
exercising problems (none was selected at this level). 220 
2.2.7. Statistical analysis  221 
The procedures were performed using software SAS Institute Inc. (2011). Gilt 222 
was the experimental unit. The normality and homoscedasticity of variables was 223 
evaluated using the Shapiro-Wilk test and examining the normal plot. Data with a normal 224 
distribution (BW, BF, loin depth, bone characteristics and WBD assessed with 225 
computerized tomography, ash and minerals in third metacarpal, and serum minerals) 226 
were analyzed using the general linear model (PROC GLM). The OC lesions scorings 227 
were evaluated using Fisher’s Exact test for presence or absence of lesions (PROC 228 
FREQ). The gait score, OC severity, number of lesions, and total lesion score were tested 229 
using non-parametric Binomial or Poisson models (PROC GENMOD). Also, the t-test 230 
was used to compare severity between knee joint faces (femur vs. tibia) and between 231 
femur or tibia face and other joint grouped severity (PROC TTEST). The main fixed 232 
effects of the model were dietary treatment and growth rate groups. In the general model, 233 
there was no evidence of dietary treatment × growth rate group interactions and was 234 
removed from the model. In all parametric analysis, Tukey–Kramer adjustments were 235 
used to determine significant (P < 0.05) differences. Linear regression was used to study 236 
the relationship between ADG for different phases (day 1 to 41, day 1 to 67, day 41 to 237 
67, day 41 to 134, day 67 to 134 and day 1 to 134) and total OC lesion score using PROC 238 
REG. 239 
3. Results 240 
The levels of Cu, Mn, and Zn were formulated to 10, 40 and 110 mg/kg, 241 
respectively, in the basal diet with an additional 10, 20, and 50 mg/kg added, respectively, 242 
to dietary treatments MIN and MM. The analyzed levels, which included the feed 243 
ingredients contribution, resulted between 10% and 50% higher levels than the 244 
formulated values (Table 1).  245 
An outbreak of porcine reproductive and respiratory syndrome (PRRS) virus 246 
occurred during this trial. Once it was detected, control measures such as vaccination and 247 
prolong the rearing phase until complete 90 days post-vaccination were applied (Fabà et 248 
al., 2018). However, for 3 weeks during the outbreak, MM gilts reduced feed intake by 249 
24% compared with other dietary treatments, and consumed 5% less feed overall than 250 
CON. Hence, the results for this treatment need to be interpreted with caution. 251 
3.1. Growth, carcass traits and whole bone density by computerized tomography 252 
Performance, carcass characteristics, bone measures, and WBD results are 253 
presented in Table 2. There was no evidence of ADG differences across dietary 254 
treatments. Because ADG was the variable used for growth classification, HG had higher 255 
slaughter BW and carcass weight than LG (P = 0.002). Carcass weight (132.7 ± 6.10 kg) 256 
and dressing percentage (77.4 ± 3.29 kg/100 kg) were not different among dietary 257 
treatments. Nevertheless, gilts from CON group had 3.4 mm greater BF depth compared 258 
to MIN, while MET and MM did not differ and had intermediate values [standard error 259 
(SE) = 0.85; P = 0.041]. Similarly, through computerized tomography, it was observed 260 
that MIN and MET gilts had 4.3 kg/100 kg leaner carcass percentage than CON; and MM 261 
was intermediate and not different (SE = 1.07; P = 0.013). The BF was 2.10 to 2.99 mm 262 
lower at day 67 for MIN, MET and MM compared to CON (SE = 0.82; P = 0.003). For 263 
BW and loin measures collected at day 1, 41, and 67 there were no differences across 264 
dietary treatments. 265 
Estimated WBD using Picouet et al. (2010) equation showed no evidence of 266 
differences across dietary treatments, but the volume (proportion) of bone above different 267 
levels of WBD (with HU values) presented some patterns. Computed tomography HU 268 
values increasing indicate higher density. The carcass WBD or proportion of bone as 269 
≥140 HU, was higher for MIN than for CON and MET (P < 0.010) dietary treatments; 270 
with MM being not different and intermediate. In addition, gilts fed MIN diet had 271 
increased volume of WBD above 500 HU than CON (P = 0.029); whilst MET and MM 272 
did not differ. Similarly, MIN and MET had 0.012 dm3 (17%) denser bone (≥1,000 HU) 273 
than CON (SE = 0.004; P < 0.050), and MM was intermediate and not different. 274 
Comparing growth groups, the WBD volume ≥ 140 HU was higher for HG than LG (P = 275 
0.004). The LG had higher percentage of bone ≥ 1,500 HU than HG (P = 0.046). Bone 276 
measurements indicated that length and area of the femur were not different across dietary 277 
treatments; however, MIN gilts had 0.7 cm larger tibia than CON and MM (SE = 0.20, P 278 
= 0.007); whilst Met was intermediate.  279 
3.2. Tibia bending test  280 
Results from tibia bone bending test indicated that breakage strength and bending 281 
moment were higher (P < 0.050) in tibia bones from MIN dietary treatment than CON; 282 
while MET and MM were not different. Total energy was greater (P = 0.026) in MIN 283 
than CON and MET dietary treatments, with MM intermediate. Contrarily, bending depth 284 
was similar across treatments. Between growth groups there were no significant 285 
differences, although HG gilts tended to have greater bending depth than LG (P = 0.058). 286 
Growth classification did not result in other bone bending differences. 287 
3.3. Analysis of minerals in third metacarpal and serum 288 
Metacarpal length was not different amongst dietary treatments nor growth group 289 
(Table 3). Conversely, the de-fatted dry content of MIN was greater (P = 0.020) than that 290 
of CON, with MET and MM being intermediate and not different. Additionally, ash, Ca, 291 
and P contents in the metacarpal were greater in MIN than in CON (P = 0.006, P = 0.007, 292 
and P = 0.010; respectively); being not different than MET and MM. Nevertheless, the 293 
ash proportion in dry matter basis and the Ca and P proportion in ash basis were not 294 
different amongst dietary treatments. Comparing the growth groups, it was observed that 295 
HG had increased metacarpal de-fatted dry weight (P = 0.029), ash content (P = 0.040), 296 
and not statistically different for content of Ca (P = 0.099) and P (P = 0.065) than LG 297 
gilts. There was no evidence of differences for Zn, Cu, and Mn content and proportion in 298 
metacarpal bone amongst dietary treatments or growth groups. Similarly, no differences 299 
were observed for serum levels of Cu and Zn among dietary treatments or growth groups. 300 
3.4. Macroscopically assessment of joint lesions   301 
Results from the joint evaluation and OC lesions detected in the joints are 302 
presented in Table 4. Articular lesions of OC were detected in 80% of gilts. Twenty 303 
percent of gilts had only small lesions, while 45% of gilts had moderate lesions, and 15% 304 
had severe lesions. Lesions were highly detected in the knee joint (68.8%) compared to 305 
elbow (21.8%), tarsal (6.3%), carpal (3.1%), and femoral-iliac joints (0%). In the knee 306 
joint, 21.8% of lesions were on the femur face and 87.5% on the tibia face. On the other 307 
hand, the severity was higher (P < 0.001) in the femur face [1.05, confidence interval (CI) 308 
= 0.798, 1.302] than on the tibia face (0.18, CI = 0.007, 0.427). Similarly, severity was 309 
higher (P = 0.037) in “other joints” (0.55; for elbow, carpal, and tarsal joints together CI 310 
= 0.232, 0.726) than on tibia (0.18, CI = 0.007, 0.427).  311 
Occurrence of OC lesions and their severity were not statistically different across 312 
dietary treatments for the faces of tibia and femur. However, the OC severity for the 313 
variable “other joints” grouped was highest (P = 0.020) for gilts fed CON diet; and not 314 
different amongst MIN, MET, and MM. The MM dietary treatment did not have any OC 315 
lesions in the tibia. At the animal level, the CON group had a higher total OC lesion score 316 
than MM (P = 0.030); whilst MIN and MET were intermediate and not different. 317 
Comparing growth rate groups (LG and HG), no evidence of differences was detected in 318 
OC lesions.  319 
Linear regressions between total score of OC and ADG within experimental 320 
periods (day 1 to 67, 67 to 134, and 1 to 134) were established. The regression results 321 
indicated that ADG from day 1 to 67 (35.8 ± 5.92 to 109.8 ± 6.12 kg of BW) may have a 322 
positive relationship with lesions. As growth rate increased, the total OC score increased 323 
(total OC score = 0.006 × ADG, g/day – 4.661; R2 = 0.10; P = 0.059). Thereafter, ADG 324 
from day 67 to 134 (up to 171.5 ± 8.05 kg of BW) showed the inverse relationship and 325 
ADG decreased with increasing total OC score (total OC score = -0.0047 × ADG, g/day 326 
+ 5.943; R2 = 0.14; P = 0.018). When assessing the whole growing period (day 1 to 134), 327 
no relationship between total OC score and growth rate was observed (total OC score = -328 
0.0044 × ADG, g/day + 5.660; R² = 0.02; P = 0.301). 329 
3.5. Locomotor ability 330 
The gait did not differ across dietary treatments or growth rate groups. Without 331 
signs of lameness, this score was maximum at 2 for a 3-point scale (10%) and was 332 
positively related to the total OC score (OC total score = 1.2095 × gait score + 1.2598; 333 
R2 = 0.27; P = 0.001). 334 
4. Discussion 335 
 The hypothesized interaction between dietary treatment and growth rate was not 336 
observed, hence removed from the models and final data was analyzed as main factors as 337 
described in the statistical analysis methods.  338 
4.1. Trace minerals 339 
Dietary TM can influence bone and joint quality, but these effects have been 340 
mainly reported when TM were fed below requirements (Owen et al., 1973; Ott and 341 
Asquith, 1989; Veum et al., 2009; Muszyński et al., 2018). Above requirements, 342 
performance maintains, excretion increases, and effects on bone development are null or 343 
controversial (Orth, 1999; Creech et al., 2004; Gowanlock et al., 2013; Olstad et al., 2015; 344 
Liu et al., 2016). Compared with CON, the dietary treatment MIN increased tibia bending 345 
moment and force, resulted in heavier metacarpal, and higher WBD. These effects could 346 
be attributed to dietary Zn, which positively correlates with bone mass (Ovesen et al., 347 
2009). High Zn is related with extracellular matrix quality and bone development by 348 
mediating with several of its components (i.e. osteoblast) or as cofactor for 349 
metalloproteinases and growth factors (Ovesen et al., 2009). This may have enhanced 350 
bone growth and trabecular thickness. Muszyński et al. (2018) did improve bone 351 
geometry, yield, and ultimate strengths, by supplementing Cu or added phytase under 352 
dietary deficiency in broilers. Conversely, Cu deficiency is not contemplated herein. 353 
Evidence of bone changes from Mn supplementation are not available and likely Zn is 354 
the TM influencing bone characteristics herein. Increasing dietary Zn to 100% of NRC 355 
(1998) and Cu to 160% of NRC (1998) linearly improved bone ash and bone strength in 356 
a 28-d study (Veum et al., 2009). Yet, the base-line of TM used herein (10, 40 and 110 357 
mg/kg of Cu, Mn, and Zn) were remarkably higher than NRC (2012) recommendations 358 
of 3.0 to 5.0 mg/kg for Cu, 2.0 to 3.0 mg/kg for Mn, and 50 to 80 mg/kg for Zn (as BW 359 
ranges in this study). Additionally, MIN and MM levels were considerably higher and 360 
provided for a longer time (134-d trial) than previous mentioned research, which make 361 
direct comparisons difficult.  362 
Other authors reported effects on bone metabolism with increasing TM 363 
availability or supplementation. Revy et al. (2004) observed that supplements of Zn or 364 
phytase increased alkaline phosphatase, and added phytase, increased Zn in metacarpal 365 
and serum, bone strength, and ash content. They reported that Zn from organic source and 366 
without phytase increased P percentage in metacarpal. This supports the positive effect 367 
on bone development when Zn is increased. Liu et al. (2016) described that TM from 368 
organic sources increased the activity of Cu, Zn-superoxide dismutase, alkaline 369 
phosphatase, and glutathione peroxidase enzymes in finishing pigs. This would enhance 370 
bone development and reduce bone loss from reactive oxygen species (Altindag et al., 371 
2008; Clarke, 2008; Smietana et al., 2011). However, the present study did not compare 372 
TM sources and whether any benefit comes from the type of source is unknown. 373 
Inconsistency across studies suggests that present results may have occurred purely by 374 
chance, or otherwise, potential of supplementing TM is limited and interact with other 375 
factors (i.e. actual risk of lameness).  376 
Metacarpal Cu and Mn were not affected by treatment, likely because bone is not 377 
the primary reservoir pool (Ma et al., 2018), but Zn was expected to increase in MIN and 378 
MM. Already high dietary base-line levels may have plateaued Zn bone content. 379 
Comparisons are difficult because TM bone content is not so often measured, and 380 
previous studies in growing pigs compare high vs. low or deletion. All present levels were 381 
high.  382 
Similar to metacarpal weight and ash content, gilts fed the MIN diet had 0.75 cm 383 
larger tibia than CON, with MET and MM having intermediate values. Obviously, initial 384 
length of the tibia was unknown but all groups were homogeneous in BW and age. 385 
Weremko et al. (2013) reported that there was a positive relation between bone size and 386 
mineralization after feed, protein, or minerals restriction. However, the present difference 387 
in tibia length is small and restriction was not applied. The higher WBD for MIN may not 388 
be strictly related to bone length but to bone growth and quality. In fact, HG had 0.60 cm 389 
larger tibia than LG, but without WBD differences; while the MIN dietary treatment 390 
maintained higher WBD than CON above 500 and 1,000 HU. Recently, Lagos et al. 391 
(2018) reported that Ca and P requirements are higher for mineralization than for growth 392 
and a similar conclusion was suggested earlier for TM requirements in turkey (Ferket et 393 
al., 2009). Nonetheless, this should be further investigated with a dose response approach.  394 
According to Orth et al. (1999) and Ytrehus et al. (2007), long bone growth is 395 
influenced by a number of growth factors, dietary factors, and other cellular signals 396 
involved in chondrocyte differentiation. Under such level of interactions, minimum 397 
intervention is attributed to diet supplements (Olstad et al., 2015; Tóth et al., 2016). 398 
Although limited, the present results suggest improvements and contrast with 399 
abovementioned research. It could be that supplementing TM only present some benefits 400 
under challenging prevalence of lameness and severity, as CON gilts exhibited 14.8% 401 
lameness and lameness reduced final BW by 7.06 kg and ADG by 80 g (Fabà et al., 2018).  402 
However, little is reported regarding lameness during rearing of gilts and its 403 
consequences; Kilbride et al. (2009) reported 11.8% prevalence.  404 
4.2. Methionine 405 
Bone properties from gilts fed MET diet were not different from MIN, and both 406 
increased dense bone (WBD >1,000 HU) compared with CON. However, MET had lower 407 
total bending energy than MIN. Slight increase of highly dense bone (>1,000 HU; 1.76% 408 
total proportion of bone) seems not to directly translate to bone strength, and greater 409 
proportion of dense bone (>500 HU; 21.7% total proportion of bone) appears more 410 
important. The role of Met in bone development seems limited and was attributed to its 411 
sulfur donator capacity (Frantz et al., 2008; Huang et al., 2014), which may be more 412 
linked to cartilage development through proteoglycan formation. Deficiency of Met 413 
delays bone differentiation and results in smaller and thinner bones (Huang et al., 2014; 414 
Ouattara et al., 2016). Whether a pathological process in the bone such as OC induce Met 415 
deficiency is unknown. However, supplementing Met induces bone tissue improvements 416 
during osteoporosis (Vijayan et al., 2014). These authors reported that Met 417 
supplementation down-regulates TLR4/MyD88/NF-κB signaling in osteoclast precursors 418 
and reduces bone loss during osteoporosis. Other sulfur sources (i.e. coenzyme A, S-419 
adenosyl methionine, glutathione, sulfate etc.) may also supply dietary sulfur with a 420 
similar objective. However, sources may have different availability and Met was selected 421 
because of previous evidence. Comparing levels above sufficiency (0.29 to 0.32 Met:Lys) 422 
with supplementing 1.10 Met:Lys, Frantz et al. (2008) also observed improvements on 423 
OC scores with Met above requirements. Therefore, greater effects than the present study 424 
may be expected under Met deficiency as current CON levels were above requirements 425 
(0.29 to 0.34 Met:Lys ratio).  426 
4.3. Trace minerals and methionine 427 
The dietary treatments MIN and MET improved WBD ≥ 500 compared to CON, 428 
however, the combination MM was intermediate, which also had intermediate values for 429 
bone strength and suggest some inconsistency. The reason is unknown but could be 430 
related with the PRRS outbreak. During the outbreak, MM gilts from Fabà et al. (2018) 431 
reduced feed intake compared with other treatments, and overall ADFI than CON, which 432 
would have lowered total mineral intake. Effects of PRRS include lethargy, anorexia, and 433 
immune system activation with increasing energy and amino acids demands (Badaoui et 434 
al., 2013). Such effects, if greater in MM gilts, could also be associated with the lower 435 
feed intake and BF in MM than CON. The reason behind such reduction on feed intake 436 
in MM gilts was unknown, but can reduce mineralization (Riet et al., 2013; Weremko et 437 
al., 2013) and minimize fat deposition (Whittemore, 1986), and because of this, MM gilts 438 
would show intermediate WBD, bone strength, and lower BF.  439 
4.4. Osteochondrosis 440 
The prevalence of OC (80%) is in agreement with previous reports (Busch and 441 
Wachmann, 2011; Grevenhof et al., 2012; Koning et al., 2014). Progression of OC 442 
undertakes 3 stages: OC latens, manifesta, and dissecans; and only the last includes 443 
clinical signs (Ytrehus et al., 2007). Absence of lameness was criteria for gilt selection, 444 
therefore, 100% of OC was subclinical, still, gait scoring indicated that mild difficulties 445 
in gait moderately correlated with increased severity of OC. Furthermore, 2 gilts had 446 
macroscopically severe lesions of OC dissecans without evident lameness (i.e. Figure 447 
1.d). Other authors also observed low correlation between OC and clinical lameness 448 
(Crenshaw et al., 2013; Etterlin et al., 2015). In this trial, most of the lesions were 449 
classified as moderate or small (81.3%). Likewise, Ytrehus et al. (2004) observed 10 450 
times more prevalence of OC manifesta than dissecans in heavy pigs.  451 
Total OC score reduced when combining the organic TM and Met (MM); whilst 452 
MIN and MET remained intermediate. In contrast, Frantz et al. (2008) observed a 453 
reduction of total OC score when supplementing Met, a combination of Cu and Mn, or 454 
all combined. In humans, providing dietary S-Adenosyl Met metabolite to osteoarthritis 455 
patients improved joint health and functionality (Najm et al., 2004). The use of heavy, 456 
grown gilts (221 ± 7.68 day of age) may have reduced the odds to find severe OC because 457 
as gilts become older, the possibility of OC healing increases (Aasmundstad et al., 2013; 458 
Olstad et al., 2014). Contrarily, limited meaning may be attributed to data from gilts fed 459 
MM diet due to greater PRRSv interaction with this treatment as above and previously 460 
discussed (Fabà et al., 2018). Variability was high and more sample size is required to 461 
validate these findings.  462 
Initially, ADG was positively associated with total OC score (from 35.8 to 109.8 463 
kg BW), and subsequently, negatively (from 109.8 to 171.5 kg BW). This relationship 464 
was weak, although it explains why our growth classification (overall ADG) missed any 465 
relationship of ADG to OC. Some studies reported that higher ADG increases risk of OC 466 
(Busch and Wachmann, 2011). Other authors could not find this relationship or observed 467 
interactions with the diet (Ytrehus et al., 2004, 2007; Quinn et al., 2015; Tóth et al., 2016). 468 
Present association is weak but in agreement with Grevenhof et al. (2012), as ADG 469 
positively influenced OC up to a BW thershold (90 to 109 kg). In the broader experiment 470 
by Fabà et al. (2018), lameness (7.7%) was detected between 106.8 to 129.7 kg of BW, 471 
increased with BW, and was associated with lower growth after gilts became clinically 472 
lame. Pain and disconfort are known to weaken feeding behavior and reduce ADG 473 
(Weary et al., 2009), and even before lameness, OC may lower ADFI by 25% 474 
(Munsterhjelm et al., 2015).  475 
The vascular failure origin of OC is thought to be related with problems when 476 
incorporating blood vessels into the advancing ossification, therefore, little support is 477 
currently given to other previously suspected factors such as trauma and nutrition (Olstad 478 
et al., 2015). Yet intervening causes on OC progression, healing, or heritable factors are 479 
still controversial. Present results, together with the previous discussed suggest a role of 480 
TM and Met on OC occurrence in grown gilts. 481 
Faba et al. (2018) reported that mildly lame gilts, which entered the sow herd, 482 
weaned 1.2 fewer piglets at first parity compared to none-lame gilts. Culling due to 483 
lameness (10 of 81; 12.3%), was 9 times higher in gilts than first parity sows. This, being 484 
high for CON (7 of 24) and MM (3 of 15), while null for MIN (0 of 22) and MET (0 of 485 
20). Insufficient incidence and sample size prevent firm conclusions but our data suggest 486 
that dietary treatment during rearing likely reduces lameness and enhances both 487 
performance and longevity.  488 
5. Conclusions 489 
The dietary treatment did not interact with growth rate groups, but supplementing 490 
alone organic trace mineral copper, manganese, and zinc for 134 days increased bone 491 
growth, bone density and tibia strength of developing gilts compared with the control diet. 492 
Supplementing high methionine alone also increased bone density and had intermediate 493 
values of bone bending and breakage strength. The combination trace minerals and 494 
additional methionine, presented intermediate bone mineralization and density compared 495 
with additional trace minerals, but may reduce osteochondrosis total score compared to 496 
control. Finally, the present study supports that growth rate can influence osteochondrosis 497 
total score but explains only 10% of its variance and does not negate that other factors 498 
may be more important.  499 
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Table 1.  General composition of experimental diets (phases I, II and III) offered to growing gilts (as-fed basis). 749 
  Phase I (1-14 day)   Phase II (15-91 day)   Phase III (92 -134 day) 
 Treatment1 
Ingredient, g/kg CON MIN MET MM   CON MIN MET MM   CON MIN MET MM 
               
Corn 250 250 250 250  250 250 253 253  250 250 250 250 
Wheat 100 100 100 100  112.5 112.5 97.5 97.5  300 300 298 298 
Barley 224 224 283 283  250 250 250 250  240 240 233 233 
Soybean meal 236 236 238 238  193 193 195 195  103 103 105 105 
Sunflower seed meal - - - -  - - - -  65 65 65 65 
Bakery byproduct 100 100 27 27  100 100 100 100      
Wheat middling - - - -  26 26 28 28      
Fat 40 40 43 43  21 21 21 21  3.0 3.0 3.0 3.0 
Calcium Carbonate 7.7 7.7 7.4 7.4  10.3 10.3 9.6 9.6  13.5 13.5 14.2 14.2 
Di-calcium phosphate 13.5 13.5 13.2 13.2  14.1 14.1 14.5 14.5  12.3 12.3 12.3 12.3 
Salt 4.0 4.0 4.0 4.0  4.0 4.0 4.0 4.0  4.0 4.0 4.0 4.0 
Hydroxy-analogue Met  1.8 1.8 11.6 11.6  0.3 0.3 0.86 0.86  - - 6.3 6.3 
L-Lys HCl 7.7 7.7 7.5 7.5  4.1 4.1 4.1 4.1  3.9 3.9 3.9 3.9 
L-Thr 2.1 2.1 2.1 2.1  0.8 0.8 0.8 0.8  0.4 0.4 0.4 0.4 
L-Trp 0.3 0.3 0.3 0.3  - - - -      
Aplomotec Plus1 1.0 1.0 1.0 1.0  1.0 1.0 1.0 1.0  1.0 1.0 1.0 1.0 
Premix2 4.0 4.0 4.0 4.0  4.0 4.0 4.0 4.0  4.0 4.0 4.0 4.0 
Analyzed composition                             
Moisture, g/kg 113 111 116 117  116 114 120 118  127 126 124 129 
Net energy3, MJ/kg 10.7 10.7 10.7 10.7  10.2 10.2 10.2 10.2  9.67 9.67 9.67 9.67 
Crude protein, g/kg 181 180 178 177  165 166 162 163  139 141 137 140 
Crude fat, g/kg 65.8 64.2 60.7 60.3  41.5 12.5 38.8 40  19.9 20.3 19.6 20 
Crude fiber, g/kg 33.9 33.4 32.3 33.0  35.9 34.0 35.0 35.8  45.3 44.9 45.2 45.5 
aNDFom, g/kg 150 150 157 157  140 140 139 139  150 150 150 150 
ADFom, g/kg 79.8 79.7 83.9 83.9  72.6 72.6 72.3 72.3  70.1 70.0 69.9 69.9 
Lysine, g/kg 12.5 12.6 12.4 12.5  10 9.8 9.7 10.1  7.7 7.5 7.8 7.7 
Methionine (Met), g/kg 4.3 4.1 13 12.8  2.7 2.5 9.8 10.2  2.6 2.4 5.1 5.4 
Hydroxy-analogue Met, g/kg 1.6 1.4 10.3 10.2  1.9 2.3 7.3 7.6  - - 10.2 9.9 
Total calcium3, g/kg 7.5 7.5 7.5 7.5  8.9 8.9 8.9 8.9  9.6 9.6 9.6 9.6 
Total phosphorus3, g/kg 5.6 5.6 5.6 5.6  5.9 5.9 5.9 5.9  5.7 5.7 5.7 5.7 
Copper, mg/kg 15.6 26.3 15.2 25.1  15.5 25.4 15.9 25.8  16.4 26.1 16 26.5 
Manganese, mg/kg 66.4 85.2 62.1 82.7  66.1 86 68.5 88.2  65.3 84.4 67.1 84.7 
Zinc, mg/kg 122.5 173.4 121.1 176.4   120.4 172.8 125.1 175.5   123.4 174.1 124.1 173.9 
1Treatment provided from 35.8 ± 5.9 to 171.5 ± 8.0 kg of body weight = CON, control; MIN, mineral treatment which provided the diet with 750 
additional 10, 20 and 50 mg/kg of chelated copper, manganese, and zinc, respectively (1 g/kg; Aplomotec Plus, Tecnología & Vitaminas, S.L., 751 
Alforja, Spain); MET, including additional methionine (Met) at 1.02 Met:Lys; or MM, including mineral and methionine treatments combination.  752 
2Vitamin-minerals premix provided per kg of feed: vitamin B2, 3.5 mg; vitamin B12, 0.035 mg; nicotinamide, 20 mg; folic acid, 1.25 mg; vitamin 753 
D3, 2,000 UI; vitamin A, 10, 000 IU; vitamin E, 30 mg; vitamin K3, 1 mg; vitamin B1, 1 mg; vitamin B6, 2.4 mg; D-calcium pantothenate, 14 mg; 754 
biotin, 0.125 mg; choline chloride, 400 mg; iron (from FeSO4.H2O), 120 mg; iodine (from Ca(IO3)2), 0.5 mg; copper (from CuSO4·5H2O), 10 mg; 755 
manganese (from MnO2), 40 mg; zinc (from ZnO2), 110 mg; selenium (from Na2SeO3), 0.4 mg; phytase EC 3.1.3.26, 1,500 FTU; and 756 
butylhydroxytoluene, 25 mg. 757 
3Calculated values.  758 
Table 2. Effect of dietary treatment provided to rearing gilts and growth rate group on growth performance, carcass and bone characteristics. 759 
  Treatment1    Growth2   P-value 
  CON MIN MET MM   LG HG RMSE3 Diet1 Growth2 
n 10 10 10 10   20 20     
Final performance                     
Age, day 219 222 222 222   222 221 7.41 0.782 0.607 
Body weight, kg 171 174 170 172   167 177 5.3 0.175 <0.001 
Average daily gain, g/day 874 899 877 873   838 922 27.9 0.189 <0.001 
Carcass                      
Hot weight, kg 134 132 131 134   131 136 5.18 0.840 0.002 
Dressing, kg/100 kg 78.5 76.0 77.1 77.8   78.4 76.4 3.01 0.360 0.066 
Backfat depth, mm 19.1a 15.7b 17.2ab 16.5ab   17.2 17.1 2.47 0.041 0.861 
Loin depth, mm 70.1 69.7 70.0 70.2   68.1 71.9 6.09 0.998 0.439 
Lean tissue, kg/100 kg 47.3b 51.6a 51.6a 51.3ab   49.9 51.0 3.18 0.013 0.307 
Bone measures4                   
Femur length, cm 20.3 20.9 20.6 20.6   20.4 20.7 0.51 0.124 0.096 
Femur area, cm2 9.46 9.25 9.09 9.31   9.01 9.50 0.88 0.979 0.119 
Tibia length, cm 17.8b 18.6a 18.1ab 17.9b   17.8 18.4 0.64 0.007 0.003 
Tibia area, cm2 5.91 6.01 5.88 5.90   5.83 6.02 0.47 0.874 0.243 
Tibia bending test5                     
Maximum force, kN 5.59b 6.38a 5.95ab 5.83ab   5.87 6.01 0.51 0.022 0.404 
Bending moment, kN - mm 168b 191a 179ab 175ab   176 180 15.4 0.022 0.409 
Bending depth, mm 2.77 2.75 2.75 2.52   2.52 2.87 0.53 0.726 0.058 
Total energy, kN 17.9b 22.6a 17.2b 19.4ab   19.4 19.1 3.80 0.026 0.848 
Bone density6                   
Density, g/dm3 1.53 1.55 1.55 1.53   1.55 1.54 0.029 0.141 0.144 
Volume HU > 140, dm3 3.52b 3.98a 3.62b 3.69ab   3.56 3.85 0.27 0.008 0.004 
Volume HU ≥ 500, dm3 0.73b 0.89a 0.84ab 0.75ab   0.81 0.80 0.12 0.029 0.940 
Volume HU ≥ 1,000, dm3 0.059b 0.071a 0.071a 0.060ab   0.066 0.064 0.011 0.048 0.698 
Bone HU ≥ 500, % 20.8 22.4 23.3 20.4   22.6 20.9 2.83 0.142 0.086 
Bone HU ≥ 1,000, % 1.66 1.80 1.97 1.63   1.85 1.68 0.29 0.092 0.140 
Bone HU ≥ 1,500, % 0.014 0.014 0.028 0.006   0.021 0.009 0.016 0.051 0.046 
a-bValues within a row with different superscripts differ significantly at P < 0.05.  760 
1Treatment provided from 35.8 ± 5.9 to 171.5 ± 8.0 kg of body weight = CON, control formulated to include 10, 40 and 110 mg/kg of copper (Cu), 761 
manganese (Mn), and zinc (Zn), respectively, and 0.32 methionine (Met): lysine (Lys); MIN, mineral treatment which provided additional 10, 20 762 
and 50 mg/kg of chelated Cu, Mn, and Zn, respectively (1 g/kg; Aplomotec Plus, Tecnología & Vitaminas, S.L., Alforja, Spain); MET, including 763 
additional 1.02 Met:Lys; or MM, including mineral and methionine treatments combination.  764 
2Growth = classification of the 40 gilts into 2 groups within the 4 dietary treatments according to average daily gain (ADG): low growth (LG, 838 765 
± 36.3 g/day ADG) or high growth (HG, 922 ± 31.1 g/day ADG). 766 
3RMSE = root-mean-square error. 767 
4Measurements performed using computerized tomography.  768 
5Maximum force (kN) was the breakage strength and the highest load of force; Bending moment (kN – mm) was calculated using Crenshaw et al., 769 
(1981) formula as: bending moment = (F × L)/4, where F is the maximum load (kN) and L is the distance between 2 supports (mm). Total energy 770 
was calculated as area under the curve: force (kN) x distance (mm). 771 
6Bone density was calculated as the distribution of volume according to their Hounsfield (HU) values. Density value was also estimated applying 772 
the formula developed by Picouet et al., (2010) considering HU >140 (Font-i-Furnols et al., 2015). Bone density was also expressed as the 773 
proportion of HU >500, HU >1,000, and HU >1,500 with respect to the volume with bone density HU >140.    774 
Table 3. Effect of dietary treatment provided to rearing gilts and growth rate group on ash 775 
percentage and mineral content in the third metacarpal and serum.  776 
 a-bValues within a row with different superscripts differ significantly at P < 0.05. 777 
1Treatment provided from 35.8 ± 5.9 to 171.5 ± 8.0 kg of body weight = CON, control 778 
formulated to include 10, 40 and 110 mg/kg of copper (Cu), manganese (Mn), and zinc 779 
(Zn), respectively, and 0.32 methionine (Met): lysine (Lys); MIN, mineral treatment 780 
which provided additional 10, 20 and 50 mg/kg of chelated Cu, Mn, and Zn, respectively 781 
(1 g/kg; Aplomotec Plus, Tecnología & Vitaminas, S.L., Alforja, Spain); MET, including 782 
additional 1.02 Met:Lys; or MM, including mineral and methionine treatments 783 
combination. 784 
  Treatment1   Growth2  P-value 
  CON MIN MET MM  LG HG RMSE3 Diet1 Growth2 
n 10 10 10 10  20 20     
Metacarpal           
Length, mm 7.90 8.07 7.95 7.97  7.95 7.99 0.180 0.243 0.442 
De-fatted dry content, g 18.8b 20.7a 19.3ab 19.3ab  19.1 20.0 1.11 0.020 0.029 
Ash content, g 11.8b 13.1a 12.3ab 12.4ab  12.2 12.7 0.698 0.006 0.040 
    Ash4, g/kg 639 637 638 645  642 637 15.2 0.752 0.367 
Calcium content, g 4.32b 4.84a 4.50ab 4.58ab  4.48 4.64 0.232 0.007 0.099 
     Calcium5, g/kg 366 368 366 368  369 366 5.12 0.685 0.124 
Phosphorous content, g 2.09b 2.29a 2.14ab 2.16ab  2.13 2.21 0.113 0.010 0.065 
     Phosphorous5, g/kg 174 174 174 174  174 174 1.60 0.907 0.322 
Zinc content, mg 2.59 2.82 2.62 2.81  41.3 43.6 0.262 0.245 0.222 
     Zinc5, mg/kg 215 214 214 226  218 218 17.8 0.502 0.810 
Copper content, µg 6.00 7.26 6.15 8.30  6.23 7.23 2.710 0.292 0.133 
     Copper5, mg/kg 5.23 5.63 5.15 6.61  5.24 6.06 2.172 0.459 0.239 
Manganese content, µg 9.83 10.2 8.12 10.3  10.1 9.14 2.287 0.231 0.265 
     Manganese5, mg/kg 8.08 7.92 6.71 8.25  8.14 7.34 1.732 0.174 0.101 
Serum           
Copper, mg/L 2.77 2.77 2.75 2.58  2.69 2.75 0.276 0.436 0.517 
Zinc, mg/L 1.56 1.44 1.83 1.52  1.58 1.60 0.422 0.287 0.907 
2Growth = classification of the 40 gilts into 2 groups among the 4 dietary treatments 785 
according to average daily gain (ADG): low growth (LG, 838 ± 36.3 g/day ADG) or high 786 
growth (HG, 922 ± 31.1 g/day ADG). 787 
3RMSE = root-mean-square error. 788 
4Bone dry matter basis. 789 
5Bone ash basis.  790 
Table 4. Effect of dietary treatment provided to rearing gilts and growth rate group on gait score, osteochondrosis (OC), prevalence and severity 791 
scores on the cartilage faces of the knee (tibia and femur), elbow, carpal and femoro-iliac joints from the left half carcass. 792 
  Treatment1    Growth2   P-value 
  CON MIN MET MM   LG HG  RMSE3 Diet1 Growth2 
n 10 10 10 10   20 20       
Gait Score 0.8 0.7 0.3 0.4   0.45 0.65  0.63 0.550 0.504 
OC prevalence4, 0-1           
  Tibia 0.1 0.2 0.4 0.0   0.2 0.15  0.70 0.162 0.407 
  Femur 0.6 0.9 0.8 0.5   0.65 0.75  0.74 0.165 0.462 
  Other joints5 0.4 0.2 0.2 0.2   0.25 0.25  0.74 0.682 0.998 
OC severity6, 0-3           
  Tibia 0.1 0.2 0.4 0.0   0.2 0.15  0.70 0.110 0.705 
  Femur 1.3 1.3 1.1 0.5   0.9 1.2  0.70 0.194 0.354 
  Other joints 1.0a 0.4b 0.4b 0.4b   0.6 0.6  0.60 0.020 0.672 
Articular faces with lesion, n 1.4 1.5 1.5 0.7   1.3 1.3  0.69 0.103 0.606 
Gilts with moderate lesion, 0-1 0.7 0.5 0.6 0.1   0.9 1.0  0.70 0.082 0.999 
Gilts with severe lesion, 0-1 0.2 0.1 0.2 0.1   0.1 0.2  1.06 0.998 0.999 
Total Score7, 0-9 2.4a 1.9ab 1.9ab 0.9b   1.7 1.85  0.50 0.030 0.596 
a-bValues within a row with different superscripts differ significantly at P < 0.05. 793 
1Treatment provided from 35.8 ± 5.9 to 171.5 ± 8.0 kg of body weight = CON, control formulated to include 10, 40 and 110 mg/kg of copper (Cu), 794 
manganese (Mn), and zinc (Zn), respectively, and 0.32 methionine (Met): lysine (Lys); MIN, mineral treatment which provided additional 10, 20 795 
and 50 mg/kg of chelated Cu, Mn, and Zn, respectively (1 g/kg; Aplomotec Plus, Tecnología & Vitaminas, S.L., Alforja, Spain); MET, including 796 
additional 1.02 Met:Lys; or MM, including mineral and methionine treatments combination. 797 
2Growth = classification of the 40 gilts into 2 groups within the 4 dietary treatments according to average daily gain (ADG): low growth (LG, 838 798 
± 36.3 g/day ADG) or high growth (HG, 922 ± 31.1 g/day ADG). 799 
3RMSE = root-mean-square error. 800 
4Prevalence at each articular face as absence (0) or presence of lesion (1) 801 
5Other joints = gilts with elbow, or carpal, or tarsal OC lesions were put together due to lower incidence.  802 
6Severity on each articular face macroscopically evaluated: none (0), small (1) when the lesion involved less than 5% of the cartilage surface, 803 
moderate (2) when the lesion was 5 to 10%, and severe (3) when the lesion exceeded 10%.  804 
7Total Score as sum of severities accumulated throughout all evaluated joint faces (Fig 1.). 805 




a)  b)    808 
c)  d)    809 
Figure 1. Illustration of femur lateral condyle to macroscopically scoring the severity of 810 
osteochondrosis lesions: a) none (0); b) small (1), when the lesion involved less than 5% 811 
of the epiphysis cartilage surface; c) moderate (2), when the lesion was 5 to 10%, and d) 812 
severe (3) fragmented cartilage and lesion exceeded 10% of the cartilage surface.  813 
